• Study on the Effectiveness and Safety of Lamivudine, Dolutegravir Sodium, Cabotegravir, and Rilpivirine for Adults with HIV-1 Who Have Not Taken Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Italy Spain
  • Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

    Not recruiting

    2 1 1 1
    Czechia France Germany Greece Italy The Netherlands +2
  • Study of Ibrutinib and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia Poland Spain
  • Study on the Effectiveness and Safety of Tirbanibulin Ointment for Adults with Actinic Keratosis on the Face or Scalp

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany Italy The Netherlands Poland Spain
  • Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Czechia France Germany The Netherlands Poland Spain
  • Study on the Effects of Semaglutide on Inflammation in Patients with Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Sweden
  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia France Italy Poland
  • Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Italy Spain Sweden
  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Norway

powered by